BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2026.
World J Gastrointest Endosc. Jan 16, 2026; 18(1): 114791
Published online Jan 16, 2026. doi: 10.4253/wjge.v18.i1.114791
Table 2 Perioperative outcomes, mean ± SD
Indicator
LPD group (n = 50)
OPD group (n = 50)
t/χ2
P value
MD/OR (95%CI)
Operative time (minutes)320 ± 45285 ± 404.12< 0.001MD 35 (18.31 to 51.69)
Blood loss (mL)180 ± 60350 ± 90-11.2< 0.001MD -170 (-199.98 to -140.02)
Transfusion (no/yes)46/439/114.650.03OR 0.31 (0.09 to 1.05)
LOS (days)12 ± 315 ± 4-3.280.002MD -3 (-4.39 to -1.61)
Overall complications (no/yes)29/2125/250.680.41OR 0.72 (0.33 to 1.59)
Severe complications (CD ≥ III, no/yes)42/839/110.770.38OR 0.68 (0.25 to 1.85)
Pancreatic fistula (no/yes)44/642/80.320.58OR 0.72 (0.23 to 2.24)
DGE (no/yes)45/543/70.410.52OR 0.68 (0.20 to 2.32)
90-day readmission (no/yes)49/147/31.020.30OR 0.32 (0.03 to 3.18)
90-day mortality (no/yes)49/148/20.240.62OR 0.49 (0.04 to 5.58)


Write to the Help Desk